These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 15100671
21. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Passalacqua G, Canonica GW. Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477 [Abstract] [Full Text] [Related]
22. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Potter PC, Kapp A, Maurer M, Guillet G, Jian AM, Hauptmann P, Finlay AY. Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988 [Abstract] [Full Text] [Related]
23. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Kruszewski J, Kłos K, Sułek K. Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837 [Abstract] [Full Text] [Related]
24. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P. Am J Rhinol Allergy; 2011 Nov; 25(1):e1-6. PubMed ID: 21711959 [Abstract] [Full Text] [Related]
25. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA, Riethuisen JM, Moulaert B, DeVos C. Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [Abstract] [Full Text] [Related]
26. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Shedden A. Clin Ther; 2006 Jan; 28(1):146-7; author reply 147-9. PubMed ID: 16490589 [No Abstract] [Full Text] [Related]
27. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Horak F, Stübner P, Zieglmeyer R, Harris AG. Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447 [Abstract] [Full Text] [Related]
28. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis. Korsgren M, Andersson M, Borgå O, Larsson L, Aldén-Raboisson M, Malmqvist U, Greiff L. Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426 [Abstract] [Full Text] [Related]
29. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW. Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343 [Abstract] [Full Text] [Related]
30. Statistical study on the incidence of allergic diseases treated with desloratadine and levocetirizine at "Atopia" Allergology Medical Center, Iaşi, Romania. Grigoriu IC, Siniţchi G, Agoroaei L, Strugaru AM, Butnaru E. Rev Med Chir Soc Med Nat Iasi; 2013 Jun; 117(4):1021-7. PubMed ID: 24502085 [Abstract] [Full Text] [Related]
31. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959 [Abstract] [Full Text] [Related]
32. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Canonica GW, Tarantini F, Compalati E, Penagos M. Allergy; 2007 Apr; 62(4):359-66. PubMed ID: 17362245 [Abstract] [Full Text] [Related]
33. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Purohit A, Melac M, Pauli G, Frossard N. Br J Clin Pharmacol; 2003 Oct; 56(4):388-94. PubMed ID: 12968983 [Abstract] [Full Text] [Related]
34. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group. J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324 [Abstract] [Full Text] [Related]
35. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH. Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817 [Abstract] [Full Text] [Related]
36. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA. Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374 [Abstract] [Full Text] [Related]
38. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
39. Antihistamines: do they work? Further well-controlled trials involving larger samples are needed. Fumagalli F, Baiardini I, Pasquali M, Compalati E, Guerra L, Massacane P, Canonica GW. Allergy; 2004 Aug; 59 Suppl 78():74-7. PubMed ID: 15245363 [Abstract] [Full Text] [Related]
40. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. Dizdar EA, Sekerel BE, Keskin O, Kalayci O, Adalioglu G, Dogan C, Tuncer A. Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]